The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback